Winton Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-18,516
| Closed | -$770K | – | 749 |
|
2024
Q4 | $770K | Buy |
+18,516
| New | +$770K | 0.05% | 396 |
|
2024
Q3 | – | Sell |
-3,584
| Closed | -$426K | – | 724 |
|
2024
Q2 | $426K | Buy |
+3,584
| New | +$426K | 0.03% | 443 |
|
2023
Q4 | – | Sell |
-3,270
| Closed | -$338K | – | 821 |
|
2023
Q3 | $338K | Buy |
3,270
+851
| +35% | +$87.9K | 0.03% | 505 |
|
2023
Q2 | $294K | Sell |
2,419
-5,099
| -68% | -$620K | 0.02% | 533 |
|
2023
Q1 | $1.15M | Sell |
7,518
-3,256
| -30% | -$500K | 0.07% | 392 |
|
2022
Q4 | $1.94M | Sell |
10,774
-29,228
| -73% | -$5.25M | 0.13% | 210 |
|
2022
Q3 | $4.73M | Buy |
40,002
+3,869
| +11% | +$457K | 0.31% | 52 |
|
2022
Q2 | $5.16M | Buy |
36,133
+18,349
| +103% | +$2.62M | 0.27% | 67 |
|
2022
Q1 | $3.06M | Buy |
17,784
+9,094
| +105% | +$1.57M | 0.16% | 133 |
|
2021
Q4 | $2.21M | Buy |
8,690
+4,383
| +102% | +$1.11M | 0.13% | 196 |
|
2021
Q3 | $1.66M | Sell |
4,307
-475
| -10% | -$183K | 0.09% | 268 |
|
2021
Q2 | $1.12M | Sell |
4,782
-5,297
| -53% | -$1.25M | 0.06% | 464 |
|
2021
Q1 | $1.32M | Sell |
10,079
-3,237
| -24% | -$424K | 0.08% | 322 |
|
2020
Q4 | $1.39M | Sell |
13,316
-26,916
| -67% | -$2.81M | 0.1% | 241 |
|
2020
Q3 | $2.85M | Buy |
+40,232
| New | +$2.85M | 0.09% | 357 |
|